Medical Devices: Page 44
-
Medtronic receives CE mark for CGM sensor, boosting challenge to Abbott and Dexcom
Medtronic has made the sensor smaller and eliminated the need for fingersticks to calibrate the device, bringing a challenger to market leaders Abbott and Dexcom.
By Nick Paul Taylor • Sept. 25, 2023 -
FDA shares draft medical device harmonization plan to meet MDUFA V goal
The FDA outlined deadlines for actions it will take, including creating a mechanism for working with regulatory partners.
By Nick Paul Taylor • Sept. 25, 2023 -
Sponsored by Shyft Global Services
How can medical device OEMs support the circular economy?
Discover how medical device OEMs can be part of the circular economy for a more sustainable future.
Sept. 25, 2023 -
Hologic allies with Bayer to support uptake of contrast-enhanced mammography
The companies will provide a product package and training intended to support adoption of the imaging technique.
By Nick Paul Taylor • Sept. 22, 2023 -
Is bigger better? McKinsey predicts the return of large medtech mergers
The analysts argue that pressure to improve margins and become the partner of choice to hospitals favors large deals.
By Nick Paul Taylor • Sept. 22, 2023 -
Boston Scientific expects ‘dramatic shift’ to pulsed field ablation to fuel fast growth through 2026
Management predicts PFA’s share of the AFib ablation market will climb from less than 5% now to as much as 80% in five years.
By Nick Paul Taylor • Sept. 22, 2023 -
Hamilton Medical recalls ventilators for control board problem
The issue can cause a short circuit or lead the capacitor to lose function, interrupting ventilation.
By Elise Reuter • Sept. 21, 2023 -
CMR Surgical secures $165M for its robot expansion
The new funding will also support product innovation efforts as the company builds a position in the fast-growing robotic surgery market.
By Susan Kelly • Updated Sept. 21, 2023 -
"Government Accountability Office Building" by kafka4prez is licensed under CC BY-SA 2.0
Limited resources constrain federal oversight of medical device ads, GAO finds
U.S. agencies took 322 enforcement actions related to medtech advertising between 2018 and 2022.
By Nick Paul Taylor • Sept. 21, 2023 -
Stryker adds minimally invasive bunion device to fast-growing extremities portfolio
The company is making the case that the system reduces recurrence, scar size and opioid use.
By Nick Paul Taylor • Sept. 21, 2023 -
EU antitrust officials make surprise inspections at cardiovascular device company
The unnamed company may have violated EU rules against abusing a dominant market position, the European Commission said.
By Susan Kelly • Sept. 20, 2023 -
CMS leader defends breakthrough device reimbursement proposal at House hearing
Dora Hughes made the case for restricting the Transitional Coverage for Emerging Technologies pathway to five reviews a year.
By Nick Paul Taylor • Sept. 20, 2023 -
FDA makes device conformity testing scheme permanent to streamline assessments
The FDA has delivered on a MDUFA V commitment by turning ASCA into a permanent, voluntary accreditation program.
By Nick Paul Taylor • Sept. 20, 2023 -
Gates Foundation grants GE HealthCare $44M for AI ultrasound tech
The money will go to subsidiary Caption Health to make AI tools to help with maternal care and pediatric lung health.
By Elise Reuter • Sept. 19, 2023 -
Boston Scientific to buy back pain treatment company Relievant for $850M
The company, which makes a treatment for chronic back pain, is expected to bring in more than $70 million in sales this year.
By Elise Reuter • Sept. 19, 2023 -
J&J starts trial of pulsed field ablation catheter with mapping feedback
Omnypulse expands J&J’s portfolio of investigational devices with a catheter that gathers contact force data.
By Nick Paul Taylor • Sept. 19, 2023 -
FDA releases draft guidance for studying weight loss devices
The documents arrive amid questions about whether new medicines will cut demand for weight loss procedures.
By Nick Paul Taylor • Sept. 19, 2023 -
MedTech Europe says MDR, IVDR framework needs ‘structural reform’
Patients may face delayed access to treatments unless changes are made to the new regulatory system, 35 European trade groups warned in an open letter.
By Susan Kelly • Sept. 18, 2023 -
FDA finalizes breakthrough device changes to target health inequities
The proposals received positive feedback from groups including AdvaMed, leading the FDA to finalize the changes with only minor revisions.
By Nick Paul Taylor • Sept. 18, 2023 -
Beacon Biosignals receives FDA clearance for sleep tracking headband
The company’s at-home device, the Dreem 3S, has six EEG electrodes to capture brain activity.
By Nick Paul Taylor • Sept. 18, 2023 -
Q&A
Bigfoot CEO talks Abbott acquisition, future of diabetes tech
Jeffrey Brewer hopes to see more integrated solutions for people with diabetes, starting with the company’s partnership with Abbott.
By Elise Reuter • Sept. 15, 2023 -
Hospital, lab equipment makers brace for China demand slowdown
Chinese purchases represent 10% to 20% of revenues on average for leading companies in the life science tools sector, according to Jefferies research.
By Susan Kelly • Sept. 15, 2023 -
J&J to phase out Janssen name in corporate rebrand
Janssen will be recast as Johnson & Johnson Innovative Medicine, while the company’s medical device business will remain Johnson & Johnson MedTech.
By Ned Pagliarulo • Sept. 15, 2023 -
GE HealthCare partners with Mayo Clinic to accelerate work on imaging and AI
The organizations will collaborate on the application of AI to MRI and the automation of diagnostic and interventional ultrasound.
By Nick Paul Taylor • Sept. 15, 2023 -
Insulin pump-makers grapple with questions about GLP-1s
The new class of weight loss drugs has caused a stock selloff, but is unlikely to “meaningfully change the long-term outlook for diabetes,” analysts wrote.
By Elise Reuter • Sept. 14, 2023